Atlas Trials

Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease

Clinical trial NCT00252122 · TERMINATED

Trial details

NCT number
NCT00252122
Sponsor
Children's Hospital of Philadelphia
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2004-06-01
Primary completion
2005-11-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.